Bolt Biotherapeutics

Investment area
Novo Ventures
Region
Western USA
Date of investment
September 2016

Bolt Biotherapeutics is developing its novel BoltbodyTM platform for cancer immunotherapy that consists of Immune-Stimulating Antibody Conjugates (ISAC)

Bolt Biotherapeutics

Investment area
Novo Ventures
Region
Western USA
Date of investment
September 2016

Bolt Biotherapeutics is developing its novel BoltbodyTM platform for cancer immunotherapy that consists of Immune-Stimulating Antibody Conjugates (ISAC)

Bolt Biotherapeutics

Investment area
Novo Ventures
Region
Western USA
Date of investment
September 2016

Bolt Biotherapeutics is developing its novel BoltbodyTM platform for cancer immunotherapy that consists of Immune-Stimulating Antibody Conjugates (ISAC)